Evaluation of the efficiency of modified PAMAM dendrimer with low molecular weight protamine peptide to deliver IL-12 plasmid into stem cells as cancer therapy vehicles
Interleukin 12 (IL-12) is taken into account as an necessary molecule for most cancers immunotherapy with vital roles in hindering tumor exercise, largely mediated by tumor-associated macrophages and anti-angiogenic components. Mesenchymal stem cells (MSCs) supply has been come out as a promising technique to extend the buildup of drug/gene in tumor websites. As a automobile, […]
Continue Reading